The results of this report can be used as a supplement to the clinical decision-making process and reduce the cost and time associated with a trial-and-error treatment. The report can be used to optimize therapy for nearly 200 commonly prescribed drugs in multiple treatment categories,including statins, platelet aggregation inhibitors, biguanides, sulfonylureas, anticoagulants, beta blockers, antihypertensives, proton pump inhibitors, non-steroidal anti-inflammatory drugs, and antiarrhythmics. In a study conducted by the Medical University of Vienna, the fraction of patients with an actionable genetic profile was 69% for warfarin, 28.5% for clopidogrel, 23% for tacrolimus, 25.7% for simvastatin, and 9.1% for thiopurines.In a recent review conducted by King’s College London, thirty-three economic evaluations ( 75%) supported PGx-guided treatment, 11 studies ( 25%) found PGx cost-effective, and 22 studies ( 50%) showed that it was dominant and cost-saving.They may not have sufficient relief from pain as they will be unable to convert codeine into its active form. These individuals may experience symptoms of extreme sleepiness, shallow breathing, and even confusion. Codeine, a commonly used pain medication, is poorly metabolized by CYP2D6 ultra-rapid metabolizers.Research on the benefits of pharmacogenomic recommendations in the long-term care of patients showed that nearly 50% of the patients had to change one to three drugs, with significant estimated savings annually.The CYP2D6 gene processes 25% of all cytochrome-metabolized drugs.75% of patients have detectable changes in their DNA that impact drug metabolism 100+ drugs carry product label FDA guidance on pharmacogenetic testing.Adverse Drug Reactions (ADRs) are estimated to be between the 4th and 6th leading cause of death in the US.Some interesting facts about genes and your medications: It also helps to reduce the cost and time associated with a trial-and-error approach to treatment. Pharmacogenomic tests provide information about a person’s genetic makeup to help the physician decide which medications and what doses might work best for him or her. Hence, they might respond differently to certain medications. Each individual has a unique genetic makeup. Your genes produce drug-metabolizing enzymes, drug targets, and other proteins related to the action of drugs. This will help your physician understand your metabolic responses and prescribe the right drug. Williams was last on an NFL roster in 2016 when he was with the Kansas City Chiefs during training camp.Xcode Life’s Personalized Medicine report targets genes that are associated with your response to drug therapies. In his lone season with the Bills in 2014, Williams caught eight passes for 142 yards and one touchdown in nine games. His best year came in 2012 when he caught 63 passes for 996 yards and nine touchdowns in 16 games. In his four seasons in Tampa, Williams, who finished second in 2010 Offensive Rookie of the Year voting, caught 215 passes for 2,947 yards and 25 touchdowns in 54 games, posting at least 900 receiving yards during the 20 seasons. He spent the first four seasons of his career with the Bucs before being traded to the Buffalo Bills in 2014. He's also tied with Marvin Harrison for second in receiving touchdowns (20). The Tampa Bay Buccaneers selected Williams in the fourth round of the 2010 draft out of Syracuse, where he ranks ninth in career receptions (133) and eighth in receiving yards (2,044). "We need prayer warriors to continue praying and spread the word," Lyle said.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |